The role of dead-end in germ-cell tumor development
- PMID: 17905939
- PMCID: PMC2518318
- DOI: 10.1196/annals.1411.006
The role of dead-end in germ-cell tumor development
Abstract
Testicular germ-cell tumors occur in human males of all age groups, from infants to men over 50 years old. Most commonly, germ-cell tumors (generally known as testicular cancer) occur in young males between the ages of 15 to 35 years. The tumor tissues are usually histologically diverse, and testicular tumors that occur in the different age groups tend to be of specific histological subtypes. Most germ-cell tumors originate from primordial germ cells during embryonic development, although the progression and eventual detection of the disease occurs decades later in humans. Mouse strains spontaneously develop a specific subtype of testicular germ-cell tumors, the type I germ-cell tumors, and these tumors are similar to the germ-cell tumors (or teratomas) that occur in human infants. Some mouse strains, such as the 129-Ter strain, have extremely high germ-cell tumor incidences, making such strains ideal for genetic and biological studies of germ cell-tumor development. Here a brief overview of the recently identified genetic defect in the Ter strain, inactivation of the dead-end (Dnd1) gene, and the ongoing studies on Dnd1 to understand its role in germ-cell and germ cell-tumor development, are provided.
Figures

Similar articles
-
What leads from dead-end?Cell Mol Life Sci. 2007 Jun;64(11):1317-22. doi: 10.1007/s00018-007-6433-3. Cell Mol Life Sci. 2007. PMID: 17464447 Free PMC article. Review.
-
The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.Nature. 2005 May 19;435(7040):360-4. doi: 10.1038/nature03595. Nature. 2005. PMID: 15902260 Free PMC article.
-
BAX-mediated cell death affects early germ cell loss and incidence of testicular teratomas in Dnd1(Ter/Ter) mice.Dev Biol. 2009 Apr 15;328(2):377-83. doi: 10.1016/j.ydbio.2009.01.041. Epub 2009 Feb 6. Dev Biol. 2009. PMID: 19389346 Free PMC article.
-
Search for testicular cancer gene hits dead-end.Cell Cycle. 2005 Sep;4(9):1136-8. doi: 10.4161/cc.4.9.1992. Epub 2005 Sep 6. Cell Cycle. 2005. PMID: 16082220 Review.
-
Chromosome X modulates incidence of testicular germ cell tumors in Ter mice.Mamm Genome. 2007 Dec;18(12):832-8. doi: 10.1007/s00335-007-9075-8. Epub 2007 Nov 30. Mamm Genome. 2007. PMID: 18049836 Free PMC article.
Cited by
-
Mouse dead end 1-β interacts with c-Jun and stimulates activator protein 1 transactivation.Mol Med Rep. 2015 Mar;11(3):1701-7. doi: 10.3892/mmr.2014.2950. Epub 2014 Nov 14. Mol Med Rep. 2015. PMID: 25405725 Free PMC article.
-
Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).PLoS One. 2008 May 28;3(5):e2315. doi: 10.1371/journal.pone.0002315. PLoS One. 2008. PMID: 18509452 Free PMC article.
-
Regulation of pluripotency in male germline stem cells by Dmrt1.Genes Dev. 2013 Sep 15;27(18):1949-58. doi: 10.1101/gad.220194.113. Epub 2013 Sep 12. Genes Dev. 2013. PMID: 24029916 Free PMC article.
-
Pluripotent cell derivation from male germline cells by suppression of Dmrt1 and Trp53.J Reprod Dev. 2015;61(5):473-84. doi: 10.1262/jrd.2015-059. Epub 2015 Jul 27. J Reprod Dev. 2015. PMID: 26227109 Free PMC article.
-
Screening for germline DND1 mutations in testicular cancer patients.Fam Cancer. 2010 Sep;9(3):439-42. doi: 10.1007/s10689-010-9340-y. Fam Cancer. 2010. PMID: 20411342 Free PMC article.
References
-
- Stevens LC. Experimental production of testicular teratomas in mice of strains 129, A/He, and their F1hybrids. J Natl Cancer Inst. 1970;44:923–929. - PubMed
-
- Stevens LC, Hummel KP. A description of spontaneous congenital testicular teratomas in strain 129 mice. J Natl Cancer Inst. 1957;18:719–747. - PubMed
-
- Stevens LC. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst. 1967;38:549–552. - PubMed
-
- Stevens LC. A new inbred subline of mice (129/terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst. 1973;50:235–242. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical